How to Cite this Article: Goriely A, Lord H, Lim J, Johnson D, Lester T, Firth HV, Wilkie AOM. 2010. Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in “paternal age-effect” syndromes. Am J Med Genet Part A 152A:2074–2078.
Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in “paternal age-effect” syndromes†
Article first published online: 15 JUL 2010
Copyright © 2010 Wiley-Liss, Inc.
American Journal of Medical Genetics Part A
Volume 152A, Issue 8, pages 2067–2073, August 2010
How to Cite
Goriely, A., Lord, H., Lim, J., Johnson, D., Lester, T., Firth, H. V. and Wilkie, A. O.M. (2010), Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in “paternal age-effect” syndromes. Am. J. Med. Genet., 152A: 2067–2073. doi: 10.1002/ajmg.a.33513
- Issue published online: 20 JUL 2010
- Article first published online: 15 JUL 2010
- Manuscript Accepted: 24 APR 2010
- Manuscript Received: 2 FEB 2010
- Wellcome Trust
- 2008. A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations. Proc Natl Acad Sci USA 105: 10143–10148. , , , .
- 2004. Progressive postnatal craniosynostosis and increased intracranial pressure. Plast Reconstr Surg 113: 1313–1323. , , , , , , , .
- 2000. The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet 1: 40–47. .
- 2000. Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet 66: 768–777. , , , , , , , , , , , .
- 2003. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301: 643–646. , , , , .
- 2005. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci USA 102: 6051–6056. , , , , , , .
- 2009. Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet 41: 1247–1252. , , , , , , , , , .
- 2006. Somatic mosaicism for an HRAS mutation causes Costello syndrome. Am J Med Genet Part A 140A: 2163–2169. , , , , .
- 2000. Germline and somatic mosaicism in achondroplasia. J Med Genet 37: 956–958. , , , , .
- 2004. Crouzon syndrome: Phenotypic signs and symptoms of the postnatally expressed subtype. J Craniofac Surg 5: 233–240. , , .
- 2003. Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia. Am J Med Genet Part A 120A: 157–168. , , , , , , , .
- 2002. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet 70: 472–486. , , , , , , , , , , , , , , .
- 1990. Germinal mosaicism in Crouzon syndrome. Hum Genet 84: 487–488. ,
- 2008. Unilateral segmental acneiform naevus: A model disorder towards understanding fibroblast growth factor receptor 2 function in acne? Br J Dermatol 158: 1397–1399. , , , .
- 2000. Recurrence risk for sibs of children with ‘sporadic’ achondroplasia. Am J Med Genet 90: 250–251. , .
- 1996. Exclusive paternal origin of new mutations in Apert syndrome. Nat Genet 13: 48–53. , , , , , , .
- 1998. Epidermal mosaicism producing localised acne: Somatic mutation in FGFR2. Lancet 352: 704–705. , .
- 1997. Metacarpophalangeal analysis in Crouzon syndrome: Additional evidence for phenotypic convergence with the acrocephalosyndactyly syndromes. Am J Med Genet 73: 61–66. , .
- 2008. Germline mosaicism in achondroplasia detected in sperm DNA of the father of three affected sibs. Am J Med Genet Part A 146A: 784–786. , , , , , , , , .
- 1991. Germinal mosaicism in Crouzon syndrome. A family with three affected siblings of normal parents. Clin Genet 40: 29–34. , , , .
- 2008. Genetics of craniosynostosis: Genes, syndromes, mutations and genotype-phenotype correlations. Front Oral Biol 12: 107–143. , , , , .
- 2004. Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis. Hum Genet 115: 200–207. , , , , , .
- 1994. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 8: 98–103. , , , , , .
- 1988. Germinal mosaicism in Crouzon syndrome. Clin Genet 33: 145–150. .
- 1995. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 9: 173–176. , , , , , , , , , , , .
- 2009. Male-to-male transmission of Costello syndrome: G12S HRAS germline mutation inherited from a father with somatic mosaicism. Am J Med Genet Part A 149A: 315–321. , , , , , , , .
- 2007. Integrated strategy for fast and automated molecular characterization of genes involved in craniosynostosis. Clin Chem 53: 1767–1774. , , , , , , , , .
- 2006. The origin of EFNB1 mutations in craniofrontonasal syndrome: Frequent somatic mosaicism and explanation of the paucity of carrier males. Am J Hum Genet 78: 999–1010. , , , , , , , , , , , , , , , .
- 1998. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet 63: 711–716. , , , , , , , , , , , .
- 2009. The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect. PLoS Genet 5: e1000558. , , , , , , , .